These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6877687)

  • 1. Inhibition of vasopressin effects on the uterus by a synthetic analogue.
    Akerlund M; Strömberg P; Forsling ML; Melin P; Vilhardt H
    Obstet Gynecol; 1983 Sep; 62(3):309-12. PubMed ID: 6877687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist.
    Hauksson A; Akerlund M; Melin P
    Br J Obstet Gynaecol; 1988 Sep; 95(9):898-904. PubMed ID: 3191063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin effects on isolated non-pregnant myometrium and uterine arteries and their inhibition by deamino-ethyl-lysine-vasopressin and deamino-ethyl-oxytocin.
    Akerlund M; Kostrzewska A; Laudănski T; Melin P; Vilhardt H
    Br J Obstet Gynaecol; 1983 Aug; 90(8):732-8. PubMed ID: 6882706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women.
    Akerlund M; Hauksson A; Lundin S; Melin P; Trojnar J
    Br J Obstet Gynaecol; 1986 Jan; 93(1):22-7. PubMed ID: 3942702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some biological properties of an "irreversible" antagonist of neurohypophyseal hormones, deamino-[Phe(4-BrCH2CONH)2]-oxytocin, and its isosteric analogue, deamino-[Phe(4-CH3CH2CONH)2]-oxytocin.
    Pliska V; Marbach P
    Eur J Pharmacol; 1978 Jun; 49(3):213-22. PubMed ID: 658139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
    Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
    J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of vasopressin release in women with primary dysmenorrhoea and after oral contraceptive treatment--effect on uterine contractility.
    Ekström P; Akerlund M; Forsling M; Kindahl H; Laudanski T; Mrugacz G
    Br J Obstet Gynaecol; 1992 Aug; 99(8):680-4. PubMed ID: 1390475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women.
    Bossmar T; Akerlund M; Szamatowicz J; Laudanski T; Fantoni G; Maggi M
    Br J Obstet Gynaecol; 1995 Nov; 102(11):907-12. PubMed ID: 8534628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a vasopressin antagonist in women with dysmenorrhea.
    Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
    Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
    Ekström P; Juchnicka E; Laudanski T; Akerlund M
    Contraception; 1989 Jul; 40(1):39-47. PubMed ID: 2505970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M; Melin P; Maggi M
    Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity.
    Melin P; Vilhardt H; Lindeberg G; Larsson LE; Akerlund M
    J Endocrinol; 1981 Feb; 88(2):173-80. PubMed ID: 7193709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin.
    Akerlund M; Carlsson AM; Melin P; Trojnar J
    Acta Obstet Gynecol Scand; 1985; 64(6):499-504. PubMed ID: 4061066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea.
    Hauksson A; Ekström P; Juchnicka E; Laudański T; Akerlund M
    Acta Obstet Gynecol Scand; 1989; 68(1):31-4. PubMed ID: 2801028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine effects of N-alpha-triglycyl-(8-lysine)-vasopressin and 8-lysine-vasopressin in the first trimester of pregnancy.
    Laudański T; Akerlund M
    Contraception; 1980 Aug; 22(2):199-208. PubMed ID: 7449382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil blockade of pressor and uterine responses to AVP-OT analogue, oxypressin.
    Gazis D; Gonzalez G; Mendlowitz M
    Am J Physiol; 1988 Jan; 254(1 Pt 2):R75-7. PubMed ID: 3337272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
    Chen YL; Shepherd C; Spinelli W; Lai FM
    Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of estrogen and progesterone on the uterine sensitivity in vitro to neuropituitary hormones in the Brazilian marsupial Didelphis albiventris: comparison with lactating animals.
    Ladosky W; Calixto SL
    Gen Comp Endocrinol; 1984 Jan; 53(1):69-77. PubMed ID: 6325293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of naloxone on uterine contractions in patients with primary dysmenorrhea].
    Mrugacz G; Grygoruk C; Sieczyński P; Grusza M; Pietrewicz P; Pietrzycki B
    Pol Merkur Lekarski; 2013 Sep; 35(207):151-3. PubMed ID: 24224452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.